Immediate Impact

65 standout
Sub-graph 1 of 21

Citing Papers

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis
2024 Standout
9 intermediate papers

Works of Tamoore Arshad being referenced

Extrahepatic manifestations and healthcare expenditures of non-alcoholic fatty liver disease in the Medicare population
2020
Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities
2020
and 3 more

Author Peers

Author Last Decade Papers Cites
Tamoore Arshad 337 176 63 122 15 402
Jun Niu 282 134 82 105 23 437
Shuping Que 239 87 73 80 19 449
Angiola Fontanella 307 161 33 112 20 410
Dan Li 243 125 19 67 17 356
Kristina Önnerhag 300 127 103 151 14 357
Gholamreza Hemmasi 220 97 90 128 21 426
Clarissa Elysia Fu 245 111 53 101 19 376
Ruveena Bhavani Rajaram 277 130 35 121 13 389
Sharon S. Brouha 253 116 48 86 12 358
Liat Mlynarsky 272 92 41 139 13 423

All Works

Loading papers...

Rankless by CCL
2026